Skip to main content
Market Entry Sprint — reviewed package in 10 business days · from $2,500 · 35+ countries of intelligence.See pricing
GH
Market entry

I need a market-entry plan before I spend six figures.

A reviewed Market Entry Sprint for one target country (or ranked shortlist of three): pathway outline, partner shortlist, evidence gaps, and a review call.

What you get

Market Entry Sprint — $2,500

Delivery: 10 business days

  • Source-tagged regulatory pathway outline
  • Reimbursement and evidence flags to verify
  • Distributor shortlist (5) with rationale
  • Gap list, next actions, and 60-minute review call

Not included

  • • Regulatory or reimbursement guarantees
  • • Guaranteed distributor or hospital contracts
  • • Patient-specific or clinical advice
GHMAP provides market-access intelligence and reviewed planning packages. It does not provide diagnosis, treatment advice, legal advice, regulatory approval, reimbursement guarantees, or investment advice. See Disclaimer.